The impact of Dimethyl itaconate on c-Fos expression in the spinal cord in experimental pain models

Copyright © 2024 Elsevier B.V. All rights reserved..

Itaconate has been found to have potent anti-inflammatory effects and is being explored as a potential treatment for inflammatory diseases. However, its ability to relieve nociception and the mechanisms behind it are not yet understood. Our research aims to investigate the nociception-relieving properties of dimethyl itaconate (DMI) in the formalin test and writhing test. In male Wistar rats, Itaconic acid was injected intraperitoneally (i.p.). The formalin test and writhing test were conducted to determine the nociceptive behaviors. The spinal cords were removed from the rats and analyzed for c-fos protein expression. The study found that administering DMI 10 and 20 mg/kg reduced nociception in formalin and writhing tests. Injection of formalin into the periphery of the body led to an increase in the expression of c-fos in the spinal cord, which was alleviated by DMI 20 mg/kg. Similarly, acetic acid injection into the peritoneal cavity caused an increase in c-fos expression in the spinal cord, which was then reduced by 20 mg/kg. According to our findings, DMI reduced nociception in rats during the formalin and writhing tests. One possible explanation for this outcome is that the decrease in c-fos protein expression may be attributed to the presence of DMI.

Medienart:

E-Artikel

Erscheinungsjahr:

2024

Erschienen:

2024

Enthalten in:

Zur Gesamtaufnahme - volume:828

Enthalten in:

Neuroscience letters - 828(2024) vom: 01. Apr., Seite 137741

Sprache:

Englisch

Beteiligte Personen:

Abbaszadeh, Mohammad [VerfasserIn]
Ghotbeddin, Zohreh [VerfasserIn]
Tabandeh, Mohammad Reza [VerfasserIn]
Rahimi, Kaveh [VerfasserIn]

Links:

Volltext

Themen:

11JIB0YI93
1HG84L3525
C-fos
Dimethyl itaconate
Formaldehyde
Formalin test
Itaconic acid
Journal Article
Proto-Oncogene Proteins c-fos
Q4516562YH
Succinates
Writhing test

Anmerkungen:

Date Completed 19.04.2024

Date Revised 19.04.2024

published: Print-Electronic

Citation Status MEDLINE

doi:

10.1016/j.neulet.2024.137741

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM370109716